Lantheus Holdings, Inc. Earnings Per Share (Basic)
Lantheus Holdings, Inc. (LNTH) reported Earnings Per Share (Basic) of $1.15 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- Lantheus Holdings, Inc. earnings per share, basic for the quarter ending 2026-06-30 was $1.15, a 0.00% change year-over-year.
- Lantheus Holdings, Inc. earnings per share, basic for the quarter ending 2026-03-31 was $1.83, a 72.64% increase year-over-year.
- Lantheus Holdings, Inc. earnings per share, basic for the quarter ending 2025-12-31 was $0.83.
- Lantheus Holdings, Inc. earnings per share, basic for the quarter ending 2025-09-30 was $0.41, a 78.31% decline year-over-year.
- Lantheus Holdings, Inc. earnings per share, basic for fiscal 2025 was $3.46, a 23.45% decline from fiscal 2024.
- Lantheus Holdings, Inc. earnings per share, basic for fiscal 2024 was $4.52, a 5.64% decline from fiscal 2023.
- Lantheus Holdings, Inc. earnings per share, basic for fiscal 2023 was $4.79, a 1068.29% increase from fiscal 2022.
- Lantheus Holdings, Inc. earnings per share, basic for fiscal 2022 was $0.41.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.15 10-Q · filed 2026-08-06 | $2.98 10-Q · filed 2026-08-06 | $3.80 derived: net income ÷ weighted average shares · filed 2026-08-06 | $4.19 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2026-03-31 | $1.83 10-Q · filed 2026-05-07 | $2.65 derived: net income ÷ weighted average shares · filed 2026-05-07 | $3.04 derived: net income ÷ weighted average shares · filed 2026-05-07 | $4.20 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-12-31 | $0.83 derived: net income ÷ weighted average shares · filed 2026-02-26 | $1.23 derived: net income ÷ weighted average shares · filed 2026-02-26 | $2.39 derived: net income ÷ weighted average shares · filed 2026-08-06 | $3.46 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.41 10-Q · filed 2025-11-06 | $1.57 derived: net income ÷ weighted average shares · filed 2026-08-06 | $2.63 10-Q · filed 2025-11-06 | $2.45 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-06-30 | $1.15 10-Q · filed 2026-08-06 | $2.21 10-Q · filed 2026-08-06 | $2.03 derived: net income ÷ weighted average shares · filed 2026-08-06 | $3.93 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-03-31 | $1.06 10-Q · filed 2026-05-07 | $0.89 derived: net income ÷ weighted average shares · filed 2026-05-07 | $2.78 derived: net income ÷ weighted average shares · filed 2026-05-07 | $3.68 derived: net income ÷ weighted average shares · filed 2026-05-07 |
| 2024-12-31 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-02-26 | $1.72 derived: net income ÷ weighted average shares · filed 2026-02-26 | $2.62 derived: net income ÷ weighted average shares · filed 2026-02-26 | $4.52 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.89 10-Q · filed 2025-11-06 | $2.78 derived: net income ÷ weighted average shares · filed 2025-11-06 | $4.69 10-Q · filed 2025-11-06 | $6.20 derived: net income ÷ weighted average shares · filed 2026-02-26 |
| 2024-06-30 | $0.89 10-Q · filed 2025-08-06 | $2.80 10-Q · filed 2025-08-06 | $4.31 derived: net income ÷ weighted average shares · filed 2026-02-26 | $6.23 derived: net income ÷ weighted average shares · filed 2026-02-26 |
| 2024-03-31 | $1.91 10-Q · filed 2025-05-07 | $3.42 derived: net income ÷ weighted average shares · filed 2026-02-26 | $5.34 derived: net income ÷ weighted average shares · filed 2026-02-26 | $6.72 derived: net income ÷ weighted average shares · filed 2026-02-26 |
| 2023-12-31 | $1.51 derived: net income ÷ weighted average shares · filed 2026-02-26 | $3.44 derived: net income ÷ weighted average shares · filed 2026-02-26 | $4.81 derived: net income ÷ weighted average shares · filed 2026-02-26 | $4.79 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.93 10-Q · filed 2024-11-06 | $3.31 derived: net income ÷ weighted average shares · filed 2024-11-06 | $3.27 10-Q · filed 2024-11-06 | $1.52 derived: net income ÷ weighted average shares · filed 2025-02-26 |
| 2023-06-30 | $1.38 10-Q · filed 2024-07-31 | $1.34 10-Q · filed 2024-07-31 | -$0.41 derived: net income ÷ weighted average shares · filed 2025-02-26 | $0.49 derived: net income ÷ weighted average shares · filed 2025-02-26 |
| 2023-03-31 | -$0.04 10-Q · filed 2024-05-02 | -$1.79 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$0.89 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$0.26 derived: net income ÷ weighted average shares · filed 2025-02-26 |
| 2022-12-31 | -$1.74 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$0.84 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$0.22 derived: net income ÷ weighted average shares · filed 2025-02-26 | $0.41 10-K · filed 2025-02-26 |
| 2022-09-30 | $0.89 10-Q · filed 2023-11-02 | $1.52 derived: net income ÷ weighted average shares · filed 2023-11-02 | $2.15 10-Q · filed 2023-11-02 | $1.57 derived: net income ÷ weighted average shares · filed 2024-02-22 |
| 2022-06-30 | $0.63 10-Q · filed 2023-08-03 | $1.26 10-Q · filed 2023-08-03 | $0.67 derived: net income ÷ weighted average shares · filed 2024-02-22 | $0.48 derived: net income ÷ weighted average shares · filed 2024-02-22 |
| 2022-03-31 | $0.63 10-Q · filed 2023-05-04 | $0.04 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$0.16 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$0.55 derived: net income ÷ weighted average shares · filed 2024-02-22 |
| 2021-12-31 | -$0.59 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$0.79 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$1.19 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$1.06 10-K · filed 2024-02-22 |
| 2021-09-30 | -$0.20 10-Q · filed 2022-11-03 | -$0.59 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$0.46 10-Q · filed 2022-11-03 | |
| 2021-06-30 | -$0.39 10-Q · filed 2022-08-04 | -$0.26 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $0.13 10-Q · filed 2022-04-29 | |||
| 2020-12-31 | -$0.25 10-K · filed 2023-02-23 | |||
| 2020-09-30 | -$0.10 10-Q · filed 2021-11-04 | -$0.24 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$0.20 10-Q · filed 2021-11-04 | |
| 2020-06-30 | -$0.16 10-Q · filed 2021-07-28 | -$0.09 10-Q · filed 2021-07-28 | ||
| 2020-03-31 | $0.08 10-Q · filed 2021-05-04 | |||
| 2019-12-31 | $0.27 10-K · filed 2020-02-25 | $0.81 10-K · filed 2022-02-24 | ||
| 2019-09-30 | $0.12 10-Q · filed 2020-11-05 | $0.29 derived: net income ÷ weighted average shares · filed 2020-11-05 | $0.55 10-Q · filed 2020-11-05 | $0.89 derived: net income ÷ weighted average shares · filed 2021-02-25 |
| 2019-06-30 | $0.16 10-Q · filed 2020-07-31 | $0.42 10-Q · filed 2020-07-31 | $0.77 derived: net income ÷ weighted average shares · filed 2021-02-25 | $1.01 derived: net income ÷ weighted average shares · filed 2021-02-25 |
| 2019-03-31 | $0.26 10-Q · filed 2020-04-30 | $0.60 derived: net income ÷ weighted average shares · filed 2021-02-25 | $0.85 derived: net income ÷ weighted average shares · filed 2021-02-25 | $1.10 derived: net income ÷ weighted average shares · filed 2021-02-25 |
| 2018-12-31 | $0.35 10-K · filed 2020-02-25 | $0.59 derived: net income ÷ weighted average shares · filed 2021-02-25 | $0.84 derived: net income ÷ weighted average shares · filed 2021-02-25 | $1.06 10-K · filed 2021-02-25 |
| 2018-09-30 | $0.24 10-K · filed 2020-02-25 | $0.50 derived: net income ÷ weighted average shares · filed 2019-10-31 | $0.71 10-Q · filed 2019-10-31 | $3.27 derived: net income ÷ weighted average shares · filed 2020-02-25 |
| 2018-06-30 | $0.25 10-K · filed 2020-02-25 | $0.47 10-Q · filed 2019-07-25 | $3.04 derived: net income ÷ weighted average shares · filed 2020-02-25 | $3.27 derived: net income ÷ weighted average shares · filed 2020-02-25 |
| 2018-03-31 | $0.22 10-K · filed 2020-02-25 | $2.79 derived: net income ÷ weighted average shares · filed 2020-02-25 | $3.03 derived: net income ÷ weighted average shares · filed 2020-02-25 | $3.40 derived: net income ÷ weighted average shares · filed 2020-02-25 |
| 2017-12-31 | $2.58 10-K · filed 2019-02-20 | $2.82 derived: net income ÷ weighted average shares · filed 2020-02-25 | $3.19 derived: net income ÷ weighted average shares · filed 2020-02-25 | $3.31 10-K · filed 2020-02-25 |
| 2017-09-30 | $0.23 10-K · filed 2019-02-20 | $0.59 derived: net income ÷ weighted average shares · filed 2018-10-30 | $0.71 10-Q · filed 2018-10-30 | $0.84 derived: net income ÷ weighted average shares · filed 2019-02-20 |
| 2017-06-30 | $0.37 10-K · filed 2019-02-20 | $0.48 10-Q · filed 2018-08-01 | $0.61 derived: net income ÷ weighted average shares · filed 2019-02-20 | $0.76 derived: net income ÷ weighted average shares · filed 2019-02-20 |
| 2017-03-31 | $0.11 10-K · filed 2019-02-20 | $0.25 derived: net income ÷ weighted average shares · filed 2019-02-20 | $0.38 derived: net income ÷ weighted average shares · filed 2019-02-20 | $0.61 derived: net income ÷ weighted average shares · filed 2019-02-20 |
| 2016-12-31 | $0.13 10-K · filed 2018-02-26 | $0.27 derived: net income ÷ weighted average shares · filed 2019-02-20 | $0.50 derived: net income ÷ weighted average shares · filed 2019-02-20 | $0.84 10-K · filed 2019-02-20 |
| 2016-09-30 | $0.14 10-K · filed 2018-02-26 | $0.38 derived: net income ÷ weighted average shares · filed 2017-08-01 | $0.71 10-Q · filed 2017-11-02 | $0.84 derived: net income ÷ weighted average shares · filed 2018-02-26 |
| 2016-06-30 | $0.24 10-K · filed 2018-02-26 | $0.58 10-Q · filed 2017-08-01 | $0.71 derived: net income ÷ weighted average shares · filed 2018-02-26 | $0.89 derived: net income ÷ weighted average shares · filed 2018-02-26 |
| 2016-03-31 | $0.34 10-K · filed 2018-02-26 | $0.47 derived: net income ÷ weighted average shares · filed 2018-02-26 | $0.65 derived: net income ÷ weighted average shares · filed 2018-02-26 | -$0.17 derived: net income ÷ weighted average shares · filed 2018-02-26 |
| 2015-12-31 | $0.13 10-K · filed 2017-02-23 | $0.31 derived: net income ÷ weighted average shares · filed 2018-02-26 | -$0.57 derived: net income ÷ weighted average shares · filed 2018-02-26 | -$0.60 10-K · filed 2018-02-26 |
| 2015-09-30 | $0.18 10-K · filed 2017-02-23 | -$0.77 derived: net income ÷ weighted average shares · filed 2016-11-01 | -$0.83 10-Q · filed 2016-11-01 | -$0.86 derived: net income ÷ weighted average shares · filed 2017-02-23 |
| 2015-06-30 | -$1.29 10-K · filed 2017-02-23 | -$1.30 derived: net income ÷ weighted average shares · filed 2016-08-04 | -$1.30 derived: net income ÷ weighted average shares · filed 2017-02-23 | -$1.35 derived: net income ÷ weighted average shares · filed 2017-02-23 |
| 2015-03-31 | $0.02 10-K · filed 2017-02-23 | $0.03 derived: net income ÷ weighted average shares · filed 2017-02-23 | -$0.01 derived: net income ÷ weighted average shares · filed 2017-02-23 | |
| 2014-12-31 | $0.01 derived: net income ÷ weighted average shares · filed 2017-02-23 | -$0.04 derived: net income ÷ weighted average shares · filed 2017-02-23 | -$0.20 10-K · filed 2017-02-23 | |
| 2014-09-30 | -$0.05 derived: net income ÷ weighted average shares · filed 2015-11-04 | -$0.21 derived: net income ÷ weighted average shares · filed 2015-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |